HPV Awareness Day 2026: Why It Matters More Than Ever
CAPItello-281 Trial at ASCO GU : Capivasertib Plus Abiraterone in PTEN-Deficient mHSPC
KEYNOTE-B15: Perioperative Enfortumab Vedotin Plus Pembrolizumab in Muscle-Invasive Bladder Cancer
LITESPARK-022 Update: Adjuvant Belzutifan + Pembrolizumab in High-Risk Clear Cell Renal Cell Carcinoma
Key Insights from the OncoDaily Global Summit: How I Treat Gallbladder and Bile Duct Cancer in 2026
UC San Diego School of Medicine Launches New Precision Medicine Therapeutics in Oncology Program
Margaret Duffy: €8M Horizon Europe Grant to Advance THEO-260 Into Phase 2a Trials
Yüksel Ürün: ASCO Guideline Update on WBC Growth Factors in Chemotherapy
